Patents Assigned to Bexson Biomedical, Inc.
  • Complexing agent salt formulations of pharmaceutical compounds
    Patent number: 11534454
    Abstract: Provided herein are pharmaceutical formulations and pharmaceutical compound salts which utilize complexing agents as counterions. Such formulations and salts are useful for treating a variety of disease and disorders.
    Type: Grant
    Filed: December 9, 2021
    Date of Patent: December 27, 2022
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach
  • Ketamine formulation for subcutaneous injection
    Patent number: 10973780
    Abstract: Provided herein are subcutaneous formulations of ketamine that are useful for treating a variety of disease and disorders. The subcutaneous ketamine formulations provided herein reduce injection site irritation and pain.
    Type: Grant
    Filed: May 14, 2020
    Date of Patent: April 13, 2021
    Assignee: Bexson Biomedical, Inc.
    Inventors: Jeffrey Becker, Gregg Peterson, Jason Wallach